• Commitments received for $9.5M placement at $0.075 per share
• Placement supported by existing and new institutional investors
• Proceeds to support commercialization and working capital

Control Bionics Limited has announced a capital raising of $10.0 million through a placement and a Share Purchase Plan (SPP). The company has received firm commitments for $9.5 million at an issue price of $0.075 per share, representing a 14.5% discount to the 5-day volume-weighted average price (VWAP) up to June 23, 2026. The placement is divided into two tranches: Tranche 1, comprising 29.6 million shares, does not require shareholder approval and will settle on June 30, 2026. Tranche 2, comprising 96.7 million shares, is subject to shareholder approval and will settle on August 11, 2026. Additionally, eligible shareholders will be invited to participate in an SPP at the same issue price, aiming to raise up to $0.5 million. The placement is supported by existing and new institutional, sophisticated, and professional investors. The proceeds will be used for commercial expansion, platform development, strategic initiatives, and working capital.

Raised $10M through placement and SPP; $9.5M commitments at $0.075 per share

The funding will support commercialization and working capital, enhancing the company's position in neurotechnology markets.